Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

Documenti analoghi

• Posttranslational Modifications of Red Blood Cell Ghost Proteins as 'Signatures' for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients
  di: Klara Pecankova, et al.
  Pubblicazione: (2017-03-01)
• Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome
  di: Májek Pavel, et al.
  Pubblicazione: (2012-05-01)
• A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneity
  di: Xiaoxiao Tang, et al.
  Pubblicazione: (2023-10-01)
• Heterogeneity of proteome dynamics between connective tissue phases of adult tendon
  di: Howard Choi, et al.
  Pubblicazione: (2020-05-01)
• Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
  di: Daniel Karel, et al.
  Pubblicazione: (2024-04-01)